Janssen Vaccines and Prevention, Janssen Pharmaceutical Companies of Johnson & Johnson, Archimedesweg 6, 2333 CN, Leiden, The Netherlands.
Sci Rep. 2019 Mar 18;9(1):4735. doi: 10.1038/s41598-019-41179-0.
Epitope characterization is critical for elucidating the mechanism of action of drug candidates. However, traditional high-resolution epitope mapping techniques are not well suited for screening numerous drug candidates recognizing a similar target. Here, we use Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) to explore the conformational impact of diverse drug molecules binding on Hemagglutinin (HA), the major surface antigen of influenza viruses. We optimized a semi-automated HDX-MS workflow to systematically probe distantly related HA subtypes in complex with 4 different drug candidates, ranging from a monoclonal antibody to a small synthetic peptide. This fast, cost-effective HDX-MS epitope mapping approach accurately determined the main antigenic site in all cases. Moreover, our studies reveal distinct changes in the local conformational dynamics of HA associated to the molecular mechanism of neutralization, establishing a marker for broad anti-HA activity. Taken together, these findings highlight the potential for HDX-MS epitope mapping-based screening to identify promising candidates against HA at early stages of drug discovery.
表位特征分析对于阐明候选药物的作用机制至关重要。然而,传统的高分辨率表位作图技术并不适用于筛选大量识别相似靶标的候选药物。在这里,我们使用氢氘交换质谱(HDX-MS)来探索不同药物分子与流感病毒主要表面抗原血凝素(HA)结合对其构象的影响。我们优化了一种半自动化的 HDX-MS 工作流程,以系统地探测与 4 种不同候选药物结合的远缘相关的 HA 亚型,这些药物候选物的范围从单克隆抗体到小合成肽。这种快速、具有成本效益的 HDX-MS 表位作图方法在所有情况下都能准确地确定主要抗原位点。此外,我们的研究揭示了与中和分子机制相关的 HA 局部构象动力学的明显变化,为广泛的抗 HA 活性建立了一个标志物。总之,这些发现强调了基于 HDX-MS 表位作图的筛选在药物发现的早期阶段识别针对 HA 的有前途候选药物的潜力。